CEO has raised concerns about China's state-backed push into mRNA technology and its implications for global competition. The ...
In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...
Amazon S3 on MSN
From COVID to cancer: How far can Moderna take mRNA technology?
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond ...
Moderna (MRNA) stock exploded 177% on melanoma vaccine trial success, marking the biggest S&P 500 gain in 20+ years. Analysts ...
As flu season approaches, local health officials are urging older adults to look into a newly approved, highly effective ...
The Food and Drug Administration has approved the first-ever mRNA flu vaccine, a shot that will use new technology to target evolving viruses and streamline vaccine production faster than traditional ...
The fate of the mRNA flu shot had been in doubt due to the Trump administration's hostility toward mRNA vaccines in the wake of the pandemic, with the FDA initially refusing to consider the vaccine.
Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 ...
On August 5, 2026, Moderna announced that the U.S. Food and Drug Administration (FDA) approved mFLUSIVA® (mRNA-1010), a seasonal influenza vaccine ...
Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. speaks as President Donald Trump listens at an event to promote his ...
Daewoong Pharmaceutical has received a patent allowance from the US Patent and Trademark Office for an ionizable lipid technology used in its eTurna messenger R ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results